TP53 and adenocarcinoma: The analysis indicates a near-significant difference in survival probabilities, particularly between females with temperature-sensitive and temperature-insensitive mutations (p = 0.053), suggesting a potential interaction between gender and TP53 mutation temperature sensitivity that may influence patient outcomes in adenocarcinoma.